These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7071529)

  • 1. Adverse reactions to polyvalent pneumococcal vaccine.
    Pönkä A; Leinonen M
    Scand J Infect Dis; 1982; 14(1):67-71. PubMed ID: 7071529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of prevaccination antibody levels with adverse reactions to pneumococcal and influenza vaccines administered simultaneously in the elderly.
    Sankilampi U; Honkanen PO; Pyhälä R; Leinonen M
    Vaccine; 1997 Jul; 15(10):1133-7. PubMed ID: 9269058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly.
    Honkanen PO; Keistinen T; Kivelä SL
    Arch Intern Med; 1996 Jan; 156(2):205-8. PubMed ID: 8546555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination.
    Mufson MA; Hughey DF; Turner CE; Schiffman G
    Vaccine; 1991 Jun; 9(6):403-7. PubMed ID: 1887670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to a 14-valent pneumococcal polysaccharide vaccine in the elderly.
    Schouten J
    Pharmatherapeutica; 1981; 3(1):1-5. PubMed ID: 7323105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal antibody levels one decade after immunization of healthy adults.
    Mufson MA; Krause HE; Schiffman G; Hughey DF
    Am J Med Sci; 1987 May; 293(5):279-84. PubMed ID: 3591818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revaccination with polyvalent pneumococcal vaccine in children with sickle cell anemia.
    Kaplan J; Sarnaik S; Schiffman G
    Am J Pediatr Hematol Oncol; 1986; 8(1):80-2. PubMed ID: 3717518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers.
    Blum MD; Dagan R; Mendelman PM; Pinsk V; Giordani M; Li S; Bohidar N; McNeely TB
    Vaccine; 2000 May; 18(22):2359-67. PubMed ID: 10738092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to polyvalent pneumococcal polysaccharide vaccine in diabetics.
    Beam TR; Crigler ED; Goldman JK; Schiffman G
    JAMA; 1980 Dec; 244(23):2621-4. PubMed ID: 7431608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of revaccination with pneumococcal polysaccharide vaccine.
    Jackson LA; Benson P; Sneller VP; Butler JC; Thompson RS; Chen RT; Lewis LS; Carlone G; DeStefano F; Holder P; Lezhava T; Williams WW
    JAMA; 1999 Jan; 281(3):243-8. PubMed ID: 9918479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal polysaccharide immunization of children with sickle cell disease. I. Clinical reactions to immunization and relationship to preimmunization antibody.
    Overturf GD; Rigau-Perez JG; Selzer J; Field RJ; Powars D; Pang EJ; Uy C; Honig G; Weiss J; Chan L; Portnoy B
    Am J Pediatr Hematol Oncol; 1982; 4(1):19-23. PubMed ID: 7091573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyvalent pneumococcal vaccines: a review.
    Hales K; Barriere SL
    Am J Hosp Pharm; 1979 Jun; 36(6):773-7. PubMed ID: 380332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyvalent pneumococcal polysaccharide vaccines.
    Hilleman MR; McLean AA; Vella PP; Weibel RE; Woodhour AF
    Bull World Health Organ; 1978; 56(3):371-5. PubMed ID: 28857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
    Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J
    Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to pneumococcal capsular polysaccharides in children with human immunodeficiency virus infection given polyvalent pneumococcal vaccine.
    Arpadi SM; Back S; O'Brien J; Janoff EN
    J Pediatr; 1994 Jul; 125(1):77-9. PubMed ID: 8021792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic reaction to pneumococcal vaccine: how common in pediatrics?
    Yousef E; Mannan S
    Allergy Asthma Proc; 2008; 29(4):397-9. PubMed ID: 18702888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults.
    Powers DC; Anderson EL; Lottenbach K; Mink CM
    J Infect Dis; 1996 Apr; 173(4):1014-8. PubMed ID: 8603942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and reactogenicity of new multivalent pneumococcal vaccines.
    Wiedermann G; Jovanovic D; Georges AM; Hauser P; Ambrosch F
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Apr; 251(4):494-504. PubMed ID: 7201725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines.
    Austrian R
    J Infect Dis; 1977 Aug; 136 Suppl():S38-42. PubMed ID: 19543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine.
    Bologa M; Kamtchoua T; Hopfer R; Sheng X; Hicks B; Bixler G; Hou V; Pehlic V; Yuan T; Gurunathan S
    Vaccine; 2012 Dec; 30(52):7461-8. PubMed ID: 23123106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.